{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:04:05Z","timestamp":1790949845831,"version":"4.1.0"},"reference-count":268,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1279,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1111\/j.1529-8019.2012.01491.x","type":"journal-article","created":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T14:33:46Z","timestamp":1339684426000},"page":"112-134","source":"Crossref","is-referenced-by-count":29,"title":["Management of cutaneous dermatomyositis"],"prefix":"10.1155","volume":"25","author":[{"given":"Christina","family":"Lam","sequence":"first","affiliation":[{"name":"Department of Dermatology; Brigham and Women's Hospital; Boston; Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Vleugels","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Brigham and Women's Hospital; Boston; Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2012,6,14]]},"reference":[{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0001|dth1491-cit-0001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clindermatol.2006.07.001","article-title":"Dermatomyositis","volume":"24","author":"Callen","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0002|dth1491-cit-0002","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0003|dth1491-cit-0003","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0004|dth1491-cit-0004","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","article-title":"Review: an update on inflammatory and autoimmune myopathies","volume":"37","author":"Dalakas","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0005|dth1491-cit-0005","first-page":"438","article-title":"Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study","volume":"35","author":"Andras","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0006|dth1491-cit-0006","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3899\/jrheum.090549","article-title":"Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA","volume":"36","author":"Antiochos","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0007|dth1491-cit-0007","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1067\/mjd.2003.208","article-title":"Dermatomyositis and malignancy in Tunisia: a multicenter national retrospective study of 20 cases","volume":"48","author":"Mebazaa","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0008|dth1491-cit-0008","first-page":"77","article-title":"Dermatomyositis and malignancy: a retrospective study of 115 cases","volume":"13","author":"Zhang","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0009|dth1491-cit-0009","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrrheum.2011.39","article-title":"Pathogenesis, classification and treatment of inflammatory myopathies","volume":"7","author":"Zong","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0010|dth1491-cit-0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archderm.138.1.114","article-title":"Dermatomyositis: practical aspects","volume":"138","author":"Jorizzo","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0011|dth1491-cit-0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00051675","article-title":"Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark","volume":"6","author":"Chow","year":"1995","journal-title":"Cancer Causes Control"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0012|dth1491-cit-0012","first-page":"1536","volume-title":"Fitzpatrick's dermatology in general medicine","author":"Sontheimer","year":"2008"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0013|dth1491-cit-0013","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.1994.03520240067043","article-title":"Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed","volume":"272","author":"Kasteler","year":"1994","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0014|dth1491-cit-0014","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2004.12.015","article-title":"Cutaneous symptoms of dermatomyositis significantly impact patients\u2019 quality of life","volume":"54","author":"Hundley","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0015|dth1491-cit-0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","article-title":"Dermatomyositis","volume":"355","author":"Callen","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0016|dth1491-cit-0016","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1517\/14656566.5.5.1083","article-title":"The management of dermatomyositis: current treatment options","volume":"5","author":"Sontheimer","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0017|dth1491-cit-0017","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/adc.51.7.501","article-title":"Dermatomyositis in childhood. Review of eight cases","volume":"51","author":"Goel","year":"1976","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0018|dth1491-cit-0018","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3346\/jkms.2009.24.4.715","article-title":"Clinical characteristics and outcomes of juvenile and adult dermatomyositis","volume":"24","author":"Na","year":"2009","journal-title":"J Korean Med Sci"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0019|dth1491-cit-0019","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-857X(02)00024-8","article-title":"Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes","volume":"28","author":"Ramanan","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0020|dth1491-cit-0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","article-title":"A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies","volume":"54","author":"Gerami","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0021|dth1491-cit-0021","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002281-199911000-00005","article-title":"Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis","volume":"11","author":"Sontheimer","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0022|dth1491-cit-0022","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","article-title":"Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?","volume":"46","author":"Sontheimer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0023|dth1491-cit-0023","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archdermatol.2009.323","article-title":"Clinically amyopathic dermatomyositis: what can we now tell our patients?","volume":"146","author":"Sontheimer","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0024|dth1491-cit-0024","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","article-title":"Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota","volume":"146","author":"Bendewald","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0025|dth1491-cit-0025","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2007.08.024","article-title":"Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center","volume":"57","author":"Klein","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0026|dth1491-cit-0026","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0190-9622(98)70496-7","article-title":"Dermatomyositis: a dermatology-based case series","volume":"38","author":"Dawkins","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0027|dth1491-cit-0027","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1586\/edm.09.52","article-title":"Dermatomyositis: current and future treatments","volume":"4","author":"Vleugels","year":"2009","journal-title":"Expert Rev Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0028|dth1491-cit-0028","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaad.2008.02.043","article-title":"The treatment and prognosis of dermatomyositis: an updated review","volume":"59","author":"Iorizzo","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0029|dth1491-cit-0029","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003643.pub2","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","author":"Choy","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0030|dth1491-cit-0030","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003643.pub3","article-title":"WITHDRAWN: immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","author":"Choy","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0031|dth1491-cit-0031","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/art.23340","article-title":"Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis","volume":"59","author":"Huber","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0032|dth1491-cit-0032","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2133.2008.08711.x","article-title":"Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis","volume":"159","author":"Klein","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0033|dth1491-cit-0033","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2133.2009.09521.x","article-title":"Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument","volume":"162","author":"Yassaee","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0034|dth1491-cit-0034","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11926-010-0100-7","article-title":"Cutaneous manifestations of dermatomyositis and their management","volume":"12","author":"Callen","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0035|dth1491-cit-0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00128071-200607060-00002","article-title":"Management of cutaneous dermatomyositis: current therapeutic options","volume":"7","author":"Quain","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0036|dth1491-cit-0036","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1085-5629(99)80028-5","article-title":"Photosensitivity in collagen vascular diseases","volume":"18","author":"Callen","year":"1999","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0037|dth1491-cit-0037","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1751-1097.1996.tb05660.x","article-title":"Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review","volume":"63","author":"Sontheimer","year":"1996","journal-title":"Photochem Photobiol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0038|dth1491-cit-0038","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0781.2004.00115.x","article-title":"Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects","volume":"20","author":"Dourmishev","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0039|dth1491-cit-0039","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2133.1994.tb08492.x","article-title":"Cutaneous photosensitivity in dermatomyositis","volume":"131","author":"Cheong","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0040|dth1491-cit-0040","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.24702","article-title":"Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women","volume":"60","author":"Love","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0041|dth1491-cit-0041","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D344B9B9XS","article-title":"Skin disease in dermatomyositis - what patients and their families often want to know","volume":"8","author":"Sontheimer","year":"2002","journal-title":"Dermatol Online J"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0042|dth1491-cit-0042","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-0536.2009.01633.x","article-title":"Bullous allergic contact dermatitis to lidocaine","volume":"61","author":"Yuen","year":"2009","journal-title":"Contact Dermat"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0043|dth1491-cit-0043","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0190-9622(83)70024-1","article-title":"Contact dermatitis caused by diphenhydramine hydrochloride","volume":"8","author":"Coskey","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0044|dth1491-cit-0044","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0738-081X(86)90019-2","article-title":"Adverse effects of corticosteroids: I. Topical and intralesional","volume":"4","author":"Coskey","year":"1986","journal-title":"Clin Dermatol"},{"issue":"Suppl. 12","key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0045|dth1491-cit-0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2133.1976.tb02273.x","article-title":"Measuring adrenal function in out-patients using topical corticosteroids","volume":"94","author":"Sparkes","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0046|dth1491-cit-0046","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00002018-200831030-00001","article-title":"The US FDA \u201cblack box\u201d warning for topical calcineurin inhibitors: an ongoing controversy","volume":"31","author":"Ring","year":"2008","journal-title":"Drug Saf"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0047|dth1491-cit-0047","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/ard.2004.032714","article-title":"Topical tacrolimus treatment in a patient with dermatomyositis","volume":"64","author":"Lampropoulos","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0048|dth1491-cit-0048","first-page":"50","article-title":"Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis","volume":"12","author":"Yoshimasu","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0049|dth1491-cit-0049","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000079903","article-title":"Topical tacrolimus in cutaneous lesions of dermatomyositis: lack of effect in side-by-side comparison in five patients","volume":"209","author":"Garcia-Doval","year":"2004","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0050|dth1491-cit-0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2133.2003.05209_4.x","article-title":"Successful treatment of amyopathic dermatomyositis with topical tacrolimus","volume":"148","author":"Ueda","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0051|dth1491-cit-0051","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/09546630310018509","article-title":"Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study","volume":"15","author":"Hollar","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0052|dth1491-cit-0052","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.revmed.2006.06.015","article-title":"Topical tacrolimus and resistant skin lesions of dermatomyositis","volume":"27","author":"Peyrot","year":"2006","journal-title":"Rev Med Interne"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0053|dth1491-cit-0053","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1067\/mjd.2001.109817","article-title":"Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety","volume":"44","author":"Soter","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0054|dth1491-cit-0054","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5021\/ad.2011.23.3.348","article-title":"Successful treatment of cutaneous lesions of dermatomyositis with topical pimecrolimus","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0055|dth1491-cit-0055","first-page":"669","article-title":"Tricyclic antidepressants and histamine H1 receptors","volume":"54","author":"Richelson","year":"1979","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0056|dth1491-cit-0056","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1610-0387.2010.07490.x","article-title":"Use of antimalarials in dermatology","volume":"8","author":"Ochsendorf","year":"2010","journal-title":"JDDG"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0057|dth1491-cit-0057","first-page":"259","volume-title":"Comprehensive dermatologic drug therapy","author":"Callen","year":"2007"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0058|dth1491-cit-0058","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0190-9622(84)80263-7","article-title":"Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine","volume":"10","author":"Woo","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0059|dth1491-cit-0059","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archderm.1995.01690240035006","article-title":"Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids","volume":"131","author":"Cosnes","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0060|dth1491-cit-0060","first-page":"1545","article-title":"Adjunctive use of hydroxychloroquine in childhood dermatomyositis","volume":"16","author":"Olson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0061|dth1491-cit-0061","first-page":"1016","article-title":"Amyopathic dermatomyositis, photosensitivity and hydroxychloroquine","volume":"132","author":"Cox","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0062|dth1491-cit-0062","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archderm.141.7.855","article-title":"Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study","volume":"141","author":"Ang","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0063|dth1491-cit-0063","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.138.9.1231","article-title":"Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus","volume":"138","author":"Pelle","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0064|dth1491-cit-0064","first-page":"1716","article-title":"Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus","volume":"25","author":"Rahman","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0065|dth1491-cit-0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archdermatol.2008.592","article-title":"Lupus erythematosus tumidus response to antimalarial treatment in 36 patients with emphasis on smoking","volume":"145","author":"Kreuter","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0066|dth1491-cit-0066","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0190-9622(00)90290-1","article-title":"Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment","volume":"42","author":"Jewell","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0067|dth1491-cit-0067","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0248-8663(04)00266-8","article-title":"Influence of smoking in the effectiveness of antimalarials drugs in cutaneous lesions of patients with lupus: estimation through a prospective study","volume":"25","author":"Lardet","year":"2004","journal-title":"Rev Med Interne"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0068|dth1491-cit-0068","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/jid.2011.167","article-title":"Clinical and pharmacogenetic influences on response to hydroxychloroquine in discoid lupus erythematosus: a retrospective cohort study","volume":"131","author":"Wahie","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0069|dth1491-cit-0069","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/jid.2011.237","article-title":"Cigarette smoking and response to antimalarials in cutaneous lupus erythematosus patients: evolution of a dogma","volume":"131","author":"Dutz","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0070|dth1491-cit-0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0071|dth1491-cit-0071","first-page":"2171","article-title":"Worsening of the rash of juvenile dermatomyositis with hydroxychloroquine therapy","volume":"21","author":"Bloom","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0072|dth1491-cit-0072","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11940-011-0119-8","article-title":"Immunotherapy of inflammatory myopathies: practical approach and future prospects","volume":"13","author":"Dalakas","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0073|dth1491-cit-0073","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-3476(96)70295-0","article-title":"Failure of pulse intravenous methylprednisolone treatment in juvenile dermatomyositis","volume":"128","author":"Lang","year":"1996","journal-title":"J Pediatr"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0074|dth1491-cit-0074","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.1780300312","article-title":"Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis","volume":"30","author":"Laxer","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0075|dth1491-cit-0075","first-page":"621","article-title":"Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy","volume":"17","author":"Huang","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0076|dth1491-cit-0076","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.122196","article-title":"Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis","volume":"47","author":"Fisler","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0077|dth1491-cit-0077","first-page":"163","volume-title":"Comprehensive dermatologic drug therapy","author":"Callen","year":"2007"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0078|dth1491-cit-0078","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1529-8019.2007.00135.x","article-title":"Methotrexate in dermatology","volume":"20","author":"Bangert","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0079|dth1491-cit-0079","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/WCO.0b013e32834a9589","article-title":"Inflammatory myopathies: management of steroid resistance","volume":"24","author":"Dalakas","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0080|dth1491-cit-0080","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(68)90649-1","article-title":"Treatment of dermatomyositis with methotrexate","volume":"2","author":"Malaviya","year":"1968","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0081|dth1491-cit-0081","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-81-2-182","article-title":"Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy","volume":"81","author":"Metzger","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0082|dth1491-cit-0082","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0190-9622(97)70327-X","article-title":"Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis","volume":"36","author":"Kasteler","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0083|dth1491-cit-0083","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0190-9622(95)91455-2","article-title":"Treatment of dermatomyositis with methotrexate","volume":"32","author":"Zieglschmid-Adams","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0084|dth1491-cit-0084","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0190-9622(98)70562-6","article-title":"The value of methotrexate in dermatomyositis","volume":"38","author":"Zieglschmid-Adams","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0085|dth1491-cit-0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2230.2011.04188.x","article-title":"Efficacy of low-dose methotrexate in the treatment of dermatomyositis skin lesions","volume":"37","author":"Hornung","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0086|dth1491-cit-0086","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/art.1780351006","article-title":"Methotrexate treatment of recalcitrant childhood dermatomyositis","volume":"35","author":"Miller","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0087|dth1491-cit-0087","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/archpedi.1979.02130040040009","article-title":"Childhood dermatomyositis and polymyositis. Treatment with methotrexate and prednisone","volume":"133","author":"Fischer","year":"1979","journal-title":"Am J Dis Child"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0088|dth1491-cit-0088","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","author":"Ramanan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0089|dth1491-cit-0089","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s100670050032","article-title":"Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate","volume":"19","author":"Al-Mayouf","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0090|dth1491-cit-0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaad.2008.08.049","article-title":"Mycophenolate mofetil in dermatology","volume":"60","author":"Orvis","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0091|dth1491-cit-0091","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/rheumatology\/keh499","article-title":"Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy","volume":"44","author":"Majithia","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0092|dth1491-cit-0092","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/01.wnl.0000208416.32471.c0","article-title":"Mycophenolate mofetil in dermatomyositis: is it safe?","volume":"66","author":"Rowin","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0093|dth1491-cit-0093","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000051674","article-title":"Mycophenolate mofetil for dermatomyositis","volume":"202","author":"Tausche","year":"2001","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0094|dth1491-cit-0094","first-page":"1542","article-title":"Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases","volume":"27","author":"Gelber","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0095|dth1491-cit-0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archderm.142.1.65","article-title":"Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis","volume":"142","author":"Edge","year":"2006","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0096|dth1491-cit-0096","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00296-010-1653-5","article-title":"Mycophenolate mofetil in juvenile dermatomyositis: a case series","volume":"32","author":"Dagher","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0097|dth1491-cit-0097","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/acr.20269","article-title":"Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis","volume":"62","author":"Rouster-Stevens","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0098|dth1491-cit-0098","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1586\/eci.10.104","article-title":"Indications and safety of intravenous and subcutaneous immunoglobulin therapy","volume":"7","author":"Rezaei","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0099|dth1491-cit-0099","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0002-9343(91)90009-M","article-title":"Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients","volume":"91","author":"Cherin","year":"1991","journal-title":"Am J Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0100|dth1491-cit-0100","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2133.1994.tb08609.x","article-title":"Paraneoplastic dermatomyositis: efficacy of intravenous gammaglobulin","volume":"131","author":"Esteve","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0101|dth1491-cit-0101","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1346-8138.1996.tb04027.x","article-title":"Successful treatment of a therapy-resistant severely pruritic skin eruption of malignancy-associated dermatomyositis with high-dose intravenous immunoglobulin","volume":"23","author":"Kikuchi-Numagami","year":"1996","journal-title":"J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0102|dth1491-cit-0102","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2169\/internalmedicine.35.663","article-title":"Intravenous immunoglobulin therapy for refractory myositis","volume":"35","author":"Moriguchi","year":"1996","journal-title":"Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0103|dth1491-cit-0103","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1346-8138.1999.tb02026.x","article-title":"Low-dose intravenous immunoglobulin therapy for intractable dermatomyositis skin lesions","volume":"26","author":"Sadayama","year":"1999","journal-title":"J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0104|dth1491-cit-0104","first-page":"29","article-title":"High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels","volume":"10","author":"Gottfried","year":"2000","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0105|dth1491-cit-0105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2340\/00015555-0016","article-title":"Successful treatment of dermatomyositis with high-dose intravenous immunoglobulin","volume":"86","author":"Kuwano","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0106|dth1491-cit-0106","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0107|dth1491-cit-0107","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10165-007-0013-0","article-title":"Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis","volume":"18","author":"Saito","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0108|dth1491-cit-0108","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2009.04.003","article-title":"Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis","volume":"9","author":"Danieli","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0109|dth1491-cit-0109","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/ard.61.1.37","article-title":"Cyclosporin A and intravenous immunoglobulin treatment in polymyositis\/dermatomyositis","volume":"61","author":"Danieli","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0110|dth1491-cit-0110","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jaad.2008.09.051","article-title":"Calcinosis cutis associated with amyopathic dermatomyositis: response to intravenous immunoglobulin","volume":"60","author":"Penate","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0111|dth1491-cit-0111","first-page":"89","article-title":"Cutaneous ulcers of refractory adult dermatomyositis responsive to intravenous immunoglobulin","volume":"62","author":"Peake","year":"1998","journal-title":"Cutis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0112|dth1491-cit-0112","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2230.1995.tb02675.x","article-title":"Dermatomyositis treated with high-dose intravenous immunoglobulins and associated with panniculitis","volume":"20","author":"Sabroe","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0113|dth1491-cit-0113","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00408-009-9146-6","article-title":"Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis\/dermatomyositis","volume":"187","author":"Suzuki","year":"2009","journal-title":"Lung"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0114|dth1491-cit-0114","first-page":"1092","article-title":"Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients","volume":"21","author":"Cherin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0115|dth1491-cit-0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/art.20913","article-title":"Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy","volume":"53","author":"Mosca","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0116|dth1491-cit-0116","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.AOG.0000253244.45837.7c","article-title":"Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy","volume":"109","author":"Williams","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0117|dth1491-cit-0117","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00296-009-1166-2","article-title":"Intravenous immunoglobulin treatment for pregnancy-associated dermatomyositis","volume":"31","author":"Linardaki","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0118|dth1491-cit-0118","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10067-008-0892-2","article-title":"Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis?","volume":"27","author":"Schleinitz","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0119|dth1491-cit-0119","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.autrev.2010.09.004","article-title":"Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application","volume":"10","author":"Danieli","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0120|dth1491-cit-0120","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.intimp.2005.11.016","article-title":"The role of high-dose immune globulin intravenous in the treatment of dermatomyositis","volume":"6","author":"Dalakas","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0121|dth1491-cit-0121","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0887-7963(03)00038-5","article-title":"Risks associated with the use of intravenous immunoglobulin","volume":"17","author":"Pierce","year":"2003","journal-title":"Transfus Med Rev"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0122|dth1491-cit-0122","first-page":"2498","article-title":"Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety","volume":"27","author":"Al-Mayouf","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0123|dth1491-cit-0123","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.72.1.25","article-title":"Intravenous immunoglobulin in juvenile dermatomyositis - four year review of nine cases","volume":"72","author":"Sansome","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0124|dth1491-cit-0124","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2133.1990.tb01462.x","article-title":"Efficacy of intravenous immunoglobulins in sclerodermatomyositis","volume":"123","author":"Bodemer","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0125|dth1491-cit-0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.1994.tb02906.x","article-title":"Juvenile dermatomyositis: treatment with intravenous gammaglobulin","volume":"130","author":"Collet","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0126|dth1491-cit-0126","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1442-200x.1999.01132.x","article-title":"Intravenous immunoglobulin treatment in a girl with juvenile dermatomyositis","volume":"41","author":"Kokori","year":"1999","journal-title":"Pediatr Int"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0127|dth1491-cit-0127","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1365-2133.2007.07891.x","article-title":"Successful treatment of cutaneous lesions in juvenile dermatomyositis with high-dose intravenous immunoglobulin","volume":"156","author":"Amano","year":"2007","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0128|dth1491-cit-0128","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1136\/ard.2011.153718","article-title":"Efficacy of intravenous Ig therapy in juvenile dermatomyositis","volume":"70","author":"Lam","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0129|dth1491-cit-0129","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1542\/peds.2007-1218","article-title":"Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content","volume":"121","author":"Manlhiot","year":"2008","journal-title":"Pediatrics"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0130|dth1491-cit-0130","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1067\/mjd.2001.114733","article-title":"Dapsone and sulfones in dermatology: overview and update","volume":"45","author":"Zhu","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0131|dth1491-cit-0131","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1529-8019.2002.01543.x","article-title":"Dapsone","volume":"15","author":"Sago","year":"2002","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0132|dth1491-cit-0132","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2230.1994.tb01220.x","article-title":"Successful treatment of dermatomyositis with dapsone","volume":"19","author":"Konohana","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0133|dth1491-cit-0133","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1365-4362.2002.01409.x","article-title":"Cutaneous involvement of dermatomyositis can respond to dapsone therapy","volume":"41","author":"Cohen","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0134|dth1491-cit-0134","first-page":"181","article-title":"Efficacy of dapsone in two cases of amyopathic dermatomyositis","volume":"81","author":"Galrao","year":"2006","journal-title":"An Bras Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0135|dth1491-cit-0135","volume-title":"Rituxan\u00ae [medication guide]","year":"2011"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0136|dth1491-cit-0136","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.2004.029694","article-title":"Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0137|dth1491-cit-0137","first-page":"1369","article-title":"Efficacy of rituximab in refractory polymyositis","volume":"32","author":"Lambotte","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0138|dth1491-cit-0138","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.rhu.0000182155.08982.60","article-title":"Rituximab in the treatment of refractory dermatomyositis","volume":"11","author":"Chiappetta","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0139|dth1491-cit-0139","first-page":"1021","article-title":"Rituximab as therapy for refractory polymyositis and dermatomyositis","volume":"33","author":"Noss","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0140|dth1491-cit-0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2006.05.068","article-title":"Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases","volume":"56","author":"Dinh","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0141|dth1491-cit-0141","first-page":"1230","article-title":"Longlasting remissions after treatment with rituximab for autoimmune myositis","volume":"35","author":"Feist","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0142|dth1491-cit-0142","first-page":"887","article-title":"Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy","volume":"26","author":"Sultan","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0143|dth1491-cit-0143","first-page":"1009","article-title":"Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature","volume":"27","author":"Rios Fernandez","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0144|dth1491-cit-0144","article-title":"Rituximab as a first-line agent for the treatment of dermatomyositis","author":"Haroon","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0145|dth1491-cit-0145","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jbspin.2007.05.011","article-title":"Successful treatment of cardiac involvement in dermatomyositis with rituximab","volume":"75","author":"Touma","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0146|dth1491-cit-0146","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.transproceed.2007.11.072","article-title":"Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus","volume":"40","author":"Kaposztas","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0147|dth1491-cit-0147","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/rheumatology\/ker088","article-title":"Rituximab treatment in patients with refractory inflammatory myopathies","volume":"50","author":"Mahler","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0148|dth1491-cit-0148","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0149|dth1491-cit-0149","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.143.6.763","article-title":"A pilot trial of rituximab in the treatment of patients with dermatomyositis","volume":"143","author":"Chung","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0150|dth1491-cit-0150","first-page":"3844","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis (DM) and adult polymyositis (PM) - the RIM Study (abstract)","volume":"62","author":"Oddis","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0151|dth1491-cit-0151","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1002\/art.22856","article-title":"Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients","volume":"56","author":"Cooper","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0152|dth1491-cit-0152","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3899\/jrheum.101321","article-title":"Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry","volume":"38","author":"Bader-Meunier","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0153|dth1491-cit-0153","first-page":"29","article-title":"Rituximab: a review of dermatological applications","volume":"2","author":"Emer","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0154|dth1491-cit-0154","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0155|dth1491-cit-0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2005.07.059","article-title":"Azathioprine in dermatology: the past, the present, and the future","volume":"55","author":"Patel","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0156|dth1491-cit-0156","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11882-008-0055-1","article-title":"Immunomodulatory treatment for dermatomyositis","volume":"8","author":"Callen","year":"2008","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0157|dth1491-cit-0157","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0049-0172(90)90024-A","article-title":"Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment","volume":"20","author":"Ramirez","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0158|dth1491-cit-0158","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","article-title":"Azathioprine with prednisone for polymyositis. A controlled, clinical trial","volume":"92","author":"Bunch","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0159|dth1491-cit-0159","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","article-title":"Prednisone and azathioprine for polymyositis: long-term followup","volume":"24","author":"Bunch","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0160|dth1491-cit-0160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/ard.41.6.557","article-title":"Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases","volume":"41","author":"Hollingworth","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0161|dth1491-cit-0161","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","article-title":"Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens","volume":"41","author":"Villalba","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0162|dth1491-cit-0162","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","article-title":"Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy","volume":"94","author":"Joffe","year":"1993","journal-title":"Am J Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0163|dth1491-cit-0163","first-page":"S53","article-title":"Randomised double blind controlled trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopathic inflammatory myopathy","volume":"199","author":"Miller","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0164|dth1491-cit-0164","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/000992288702601101","article-title":"Childhood dermatomyositis. Clinical course and long-term follow-up","volume":"26","author":"Miller","year":"1987","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0165|dth1491-cit-0165","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1542\/peds.59.2.212","article-title":"Methotrexate and azathioprine treatment of childhood dermatomyositis","volume":"59","author":"Jacobs","year":"1977","journal-title":"Pediatrics"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0166|dth1491-cit-0166","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archinte.132.4.447","article-title":"Azathioprine therapy in polymyositis","volume":"132","author":"Benson","year":"1973","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0167|dth1491-cit-0167","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.02.063","article-title":"The use of cyclosporine in dermatology: part I","volume":"63","author":"Amor","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0168|dth1491-cit-0168","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","article-title":"Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis","volume":"29","author":"Vencovsky","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0169|dth1491-cit-0169","first-page":"2855","article-title":"Cyclosporin A in the treatment of refractory adult polymyositis\/dermatomyositis: population based experience in 6 patients and literature review","volume":"27","author":"Qushmaq","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0170|dth1491-cit-0170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/03009749709065660","article-title":"Cyclosporine treatment for polymyositis\/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?","volume":"26","author":"Maeda","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0171|dth1491-cit-0171","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/014107689108400519","article-title":"Dermatomyositis treated with cyclosporin","volume":"84","author":"Kavanagh","year":"1991","journal-title":"J R Soc Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0172|dth1491-cit-0172","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/jnnp.54.11.1007","article-title":"Cyclosporin in the management of polymyositis and dermatomyositis","volume":"54","author":"Lueck","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0173|dth1491-cit-0173","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00007611-199508000-00018","article-title":"Dermatomyositis: remission induced with combined oral cyclosporine and high-dose intravenous immune globulin","volume":"88","author":"Saadeh","year":"1995","journal-title":"South Med J"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0174|dth1491-cit-0174","first-page":"381","article-title":"Cyclosporine A as first choice therapy for dermatomyositis","volume":"21","author":"Grau","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0175|dth1491-cit-0175","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00296-008-0822-2","article-title":"Dermatomyositis, complicated with pneumomediastinum, successfully treated with cyclosporine A: a case report and review of literature","volume":"29","author":"Kim","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0176|dth1491-cit-0176","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/art.1780340726","article-title":"Cyclosporin A treatment of dermatomyositis","volume":"34","author":"Danko","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0177|dth1491-cit-0177","first-page":"254","article-title":"Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute\/subacute interstitial pneumonia in dermatomyositis","volume":"35","author":"Kotani","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0178|dth1491-cit-0178","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10067-011-1713-6","article-title":"Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute\/subacute interstitial pneumonia","volume":"30","author":"Kotani","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0179|dth1491-cit-0179","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2169\/internalmedicine.42.1253","article-title":"Intractable skin necrosis and interstitial pneumonia in amyopathic dermatomyositis, successfully treated with cyclosporin A","volume":"42","author":"Shimojima","year":"2003","journal-title":"Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0180|dth1491-cit-0180","first-page":"2436","article-title":"Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis","volume":"24","author":"Reiff","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0181|dth1491-cit-0181","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(89)92456-2","article-title":"Cyclosporin in juvenile dermatomyositis","volume":"1","author":"Heckmatt","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0182|dth1491-cit-0182","first-page":"1424","article-title":"Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases","volume":"23","author":"Zeller","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0183|dth1491-cit-0183","first-page":"16","article-title":"\u201cCatch-up\u201d growth in steroid dependent dermatomyositis treated with cyclosporin-A","volume":"1","author":"Hamill","year":"1992","journal-title":"Eur J Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0184|dth1491-cit-0184","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(84)90391-X","article-title":"Cyclosporin for acute dermatomyositis","volume":"1","author":"Zabel","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0185|dth1491-cit-0185","unstructured":"PRINTO Juvenile dermatomyositis trial http:\/\/www.printo.it\/project_ongoing_detail.asp?ProjectID=14"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0186|dth1491-cit-0186","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00003495-200059020-00021","article-title":"Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation","volume":"59","author":"Plosker","year":"2000","journal-title":"Drugs"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0187|dth1491-cit-0187","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2169\/internalmedicine.44.1197","article-title":"Successful treatment with tacrolimus in a case of refractory dermatomyositis","volume":"44","author":"Mitsui","year":"2005","journal-title":"Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0188|dth1491-cit-0188","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00431-004-1497-7","article-title":"Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A","volume":"163","author":"Yamada","year":"2004","journal-title":"Eur J Pediatr"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0189|dth1491-cit-0189","first-page":"728","article-title":"FK-506 in the treatment of unresponsive juvenile dermatomyositis","volume":"59","author":"Modesto","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0190|dth1491-cit-0190","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s10067-008-0973-2","article-title":"Treatment of refractory juvenile dermatomyositis with tacrolimus","volume":"27","author":"Hassan","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0191|dth1491-cit-0191","first-page":"697","article-title":"[Efficacy of tacrolimus (FK-506) in the treatment of recalcitrant juvenile dermatomyositis: study of 6 cases]","volume":"127","author":"Martin Nalda","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0192|dth1491-cit-0192","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(99)01927-3","article-title":"Tacrolimus in refractory polymyositis with interstitial lung disease","volume":"353","author":"Oddis","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0193|dth1491-cit-0193","first-page":"707","article-title":"Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis\/dermatomyositis","volume":"23","author":"Ochi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0194|dth1491-cit-0194","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/art.21240","article-title":"Treatment of antisynthetase-associated interstitial lung disease with tacrolimus","volume":"52","author":"Wilkes","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0195|dth1491-cit-0195","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jaad.2007.05.021","article-title":"Sirolimus (rapamycin): from the soil of Easter Island to a bright future","volume":"57","author":"Paghdal","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0196|dth1491-cit-0196","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2004.05.044","article-title":"Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis","volume":"52","author":"Nadiminti","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0197|dth1491-cit-0197","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5387\/fms.48.103","article-title":"Prevention of progression of interstitial lung lesions by early combination therapy with corticosteroids and cyclosporine\/cyclophosphamide in two patients with amyopathic dermatomyositis","volume":"48","author":"Sugisaki","year":"2002","journal-title":"Fukushima J Med Sci"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0198|dth1491-cit-0198","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2169\/internalmedicine.39.428","article-title":"Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis","volume":"39","author":"Tanaka","year":"2000","journal-title":"Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0199|dth1491-cit-0199","first-page":"1592","article-title":"Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis\/dermatomyositis","volume":"16","author":"al-Janadi","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0200|dth1491-cit-0200","first-page":"724","article-title":"Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide","volume":"23","author":"Meyer","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0201|dth1491-cit-0201","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/kel112","article-title":"Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis\/dermatomyositis","volume":"46","author":"Yamasaki","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0202|dth1491-cit-0202","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/RHU.0b013e3181d59c59","article-title":"Evolution of clinically amyopathic dermatomyositis despite aggressive immunosuppression with cyclophosphamide and prednisone","volume":"16","author":"Hildebrand","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0203|dth1491-cit-0203","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/03009740310002542","article-title":"Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine","volume":"32","author":"Mok","year":"2003","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0204|dth1491-cit-0204","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2169\/internalmedicine.47.1289","article-title":"Complete resolution of dermatomyositis with refractory cutaneous vasculitis by intravenous cyclophosphamide pulse therapy","volume":"47","author":"Tsujimura","year":"2008","journal-title":"Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0205|dth1491-cit-0205","first-page":"895","article-title":"[Intravenous cyclophosphamide pulse therapy for refractory juvenile dermatomyositis]","volume":"42","author":"Nakashima","year":"2002","journal-title":"Ryumachi"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0206|dth1491-cit-0206","first-page":"309","article-title":"[Effective cyclophosphamide pulse therapy for an young infant with severe dermatomyositis]","volume":"43","author":"Senju","year":"2011","journal-title":"No To Hattatsu"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0207|dth1491-cit-0207","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/rheumatology\/keh082","article-title":"Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety","volume":"43","author":"Riley","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0208|dth1491-cit-0208","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.1780360305","article-title":"Chlorambucil. An effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis","volume":"36","author":"Sinoway","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0209|dth1491-cit-0209","first-page":"658","article-title":"Combined steroid, methotrexate and chlorambucil therapy for steroid-resistant dermatomyositis","volume":"9","author":"Cagnoli","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0210|dth1491-cit-0210","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/art.1780280523","article-title":"Combination immunosuppressive treatment of steroid-resistant dermatomyositis\/polymyositis","volume":"28","author":"Wallace","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0211|dth1491-cit-0211","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00415-011-5907-2","article-title":"Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies","volume":"258","author":"Stubgen","year":"2011","journal-title":"J Neurol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0212|dth1491-cit-0212","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/rheumatology\/keh285","article-title":"Refractory adult dermatomyositis with pneumatosis cystoides intestinalis treated with infliximab","volume":"43","author":"Selva-O'Callaghan","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0213|dth1491-cit-0213","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s10067-006-0325-z","article-title":"Treatment of early and refractory dermatomyositis with infliximab: a report of two cases","volume":"26","author":"Dold","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0214|dth1491-cit-0214","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.jaad.2005.11.1090","article-title":"Case reports of etanercept in inflammatory dermatoses","volume":"54","author":"Norman","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0215|dth1491-cit-0215","first-page":"1802","article-title":"Use of etanercept in the treatment of dermatomyositis: a case series","volume":"33","author":"Iannone","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0216|dth1491-cit-0216","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2005.048744","article-title":"Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients","volume":"65","author":"Efthimiou","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0217|dth1491-cit-0217","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0218|dth1491-cit-0218","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","article-title":"A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies","volume":"67","author":"Dastmalchi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0219|dth1491-cit-0219","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000114036","article-title":"Open-label trial of anti-TNF-(alpha) in dermato- and polymyositis treated concomitantly with methotrexate","volume":"59","author":"Hengstman","year":"2008","journal-title":"Eur Neurol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0220|dth1491-cit-0220","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22477","article-title":"A randomized, pilot trial of etanercept in dermatomyositis","volume":"70","author":"Amato","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0221|dth1491-cit-0221","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archdermatol.2010.142","article-title":"Tumor necrosis factor inhibitor-associated dermatomyositis","volume":"146","author":"Klein","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0222|dth1491-cit-0222","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3899\/jrheum.091413","article-title":"Dermatomyositis during adalimumab therapy for rheumatoid arthritis","volume":"37","author":"Brunasso","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0223|dth1491-cit-0223","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.22358","article-title":"Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor","volume":"55","author":"Hall","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0224|dth1491-cit-0224","first-page":"352","article-title":"A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures","volume":"26","author":"Adams","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0225|dth1491-cit-0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00124743-200202000-00011","article-title":"Drug-induced amyopathic dermatomyositis","volume":"8","author":"Flores-Suarez","year":"2002","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0226|dth1491-cit-0226","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1546-0096-8-6","article-title":"Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis","volume":"8","author":"Miyamae","year":"2010","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0227|dth1491-cit-0227","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.2007.073221","article-title":"Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis","volume":"67","author":"Sangle","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0228|dth1491-cit-0228","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaad.2007.08.014","article-title":"Leflunomide as adjuvant treatment of dermatomyositis","volume":"58","author":"Boswell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0229|dth1491-cit-0229","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/08916930600623874","article-title":"Anti-Jo-1 antibody positive polymyositis - successful therapy with leflunomide","volume":"39","author":"Lange","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0230|dth1491-cit-0230","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archderm.142.1.70","article-title":"Improvement in dermatomyositis rash associated with the use of antiestrogen medication","volume":"142","author":"Sereda","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0231|dth1491-cit-0231","first-page":"270","article-title":"Plasma exchange in polymyositis and dermatomyositis: a multicenter study of 57 cases","volume":"13","author":"Cherin","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0232|dth1491-cit-0232","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199205213262102","article-title":"Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis","volume":"326","author":"Miller","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0233|dth1491-cit-0233","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/ard.2010.141804","article-title":"Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis","volume":"70","author":"Wang","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0234|dth1491-cit-0234","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03009740903096622","article-title":"Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis","volume":"39","author":"Holzer","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0235|dth1491-cit-0235","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.bmt.1703048","article-title":"Dermatomyositis and sarcoid-like reaction associated with multiple myeloma treated effectively by high-dose chemotherapy and autologous peripheral blood stem cell transplantation","volume":"27","author":"Chakraverty","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0236|dth1491-cit-0236","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pcl.2009.12.003","article-title":"Autologous hematopoietic stem cell transplantation for childhood autoimmune disease","volume":"57","author":"Milanetti","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0237|dth1491-cit-0237","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/mus.880110206","article-title":"Response to total body irradiation in dermatomyositis","volume":"11","author":"Kelly","year":"1988","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0238|dth1491-cit-0238","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jbspin.2010.12.007","article-title":"Actuality of juvenile dermatomyositis","volume":"78","author":"Zouagui","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0239|dth1491-cit-0239","first-page":"661","article-title":"A case of regressive development of a diffuse calcinosis during dermatomyositis in a child","volume":"44","author":"Maurer","year":"1977","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0240|dth1491-cit-0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/adc.45.239.118","article-title":"Treatment of calcinosis universalis with aluminium hydroxide","volume":"45","author":"Nassim","year":"1970","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0241|dth1491-cit-0241","first-page":"363","article-title":"A case of calcinosis universalis complicating dermatomyositis - its treatment with aluminium hydroxide","volume":"27","author":"Kikuta","year":"1979","journal-title":"Rinsho Shoni Igaku"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0242|dth1491-cit-0242","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/archderm.1988.01670110077022","article-title":"Calcinosis cutis in juvenile dermatomyositis: remarkable response to aluminium hydroxide therapy","volume":"124","author":"Wang","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0243|dth1491-cit-0243","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1346-8138.1993.tb01338.x","article-title":"Calcinosis cutis in juvenile dermatomyositis responsive to aluminum hydroxide treatment","volume":"20","author":"Nakagawa","year":"1993","journal-title":"J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0244|dth1491-cit-0244","first-page":"879","article-title":"A case of juvenile dermatomyositis with calcinosis universalis - remarkable improvement with aluminum hydroxide therapy","volume":"34","author":"Aihara","year":"1994","journal-title":"Ryumachi"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0245|dth1491-cit-0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-4632.2009.04449.x","article-title":"A case of juvenile dermatomyositis with severe calcinosis and successful treatment with prednisone and diltiazem","volume":"50","author":"Jiang","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0246|dth1491-cit-0246","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/rheumatology\/39.3.333","article-title":"Regression of calcinosis associated with adult dermatomyositis following diltiazem therapy","volume":"39","author":"Vinen","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0247|dth1491-cit-0247","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1365-2133.2001.04153.x","article-title":"An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem","volume":"144","author":"Ichiki","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0248|dth1491-cit-0248","first-page":"102","article-title":"Regression of cutis calcinosis with diltiazem in adult dermatomyositis","volume":"15","author":"Abdallah-Lotf","year":"2005","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0249|dth1491-cit-0249","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/archdermatol.2011.2052","article-title":"Calcinosis cutis occurring in association with autoimmune connective tissue disease: the mayo clinic experience with 78 patients, 1996-2009","volume":"148","author":"Balin","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0250|dth1491-cit-0250","doi-asserted-by":"crossref","first-page":"456e","DOI":"10.1097\/PRS.0b013e3181bcf703","article-title":"Massive gluteal calcinosis in a 10-year-old girl with juvenile dermatomyositis: successful surgical management","volume":"124","author":"Vitale","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0251|dth1491-cit-0251","first-page":"169","article-title":"Tumorous feature of calcinosis: unusual sequelae of juvenile dermatomyositis","volume":"28","author":"Thellier","year":"2009","journal-title":"Nouv Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0252|dth1491-cit-0252","doi-asserted-by":"crossref","first-page":"648","DOI":"10.7326\/0003-4819-89-5-648","article-title":"Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis","volume":"89","author":"Taborn","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0253|dth1491-cit-0253","first-page":"527","article-title":"Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis","volume":"5","author":"Fuchs","year":"1986","journal-title":"Clin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0254|dth1491-cit-0254","first-page":"1129","article-title":"Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications","volume":"28","author":"Harel","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0255|dth1491-cit-0255","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.62.3.267","article-title":"Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline","volume":"62","author":"Robertson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0256|dth1491-cit-0256","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jbspin.2009.04.011","article-title":"Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate","volume":"77","author":"Slimani","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0257|dth1491-cit-0257","first-page":"1837","article-title":"Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy","volume":"32","author":"Ambler","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0258|dth1491-cit-0258","first-page":"135","article-title":"Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis","volume":"28","author":"Marco Puche","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0259|dth1491-cit-0259","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00774-011-0289-1","article-title":"Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy","volume":"30","author":"Mori","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0260|dth1491-cit-0260","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1111\/j.1756-185X.2010.01483.x","article-title":"Localized calcinosis in juvenile dermatomyositis: successful treatment with intralesional corticosteroids injection","volume":"13","author":"Al-Mayouf","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0261|dth1491-cit-0261","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s10067-004-1023-3","article-title":"Electric shock wave lithotripsy (ESWL) as a pain control measure in dermatomyositis with calcinosis cutis - old method, new discovery","volume":"24","author":"Chan","year":"2005","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0262|dth1491-cit-0262","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaad.2010.12.035","article-title":"Treatment of calcinosis cutis by extracorporeal shock-wave lithotripsy","volume":"66","author":"Sultan-Bichat","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0263|dth1491-cit-0263","first-page":"2152","article-title":"Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis","volume":"23","author":"Oliveri","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0264|dth1491-cit-0264","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1210\/jc.82.11.3536","article-title":"Calcinosis universalis complicating juvenile dermatomyositis: resolution during probenecid therapy","volume":"82","author":"Eddy","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0265|dth1491-cit-0265","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1346-8138.1998.tb02490.x","article-title":"A case of calcinosis universalis successfully treated with low-dose warfarin","volume":"25","author":"Matsuoka","year":"1998","journal-title":"J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0266|dth1491-cit-0266","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0002-9343(87)90499-2","article-title":"Treatment of calcinosis universalis with low-dose warfarin","volume":"83","author":"Berger","year":"1987","journal-title":"Am J Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0267|dth1491-cit-0267","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0002-9343(88)90128-3","article-title":"Failure of warfarin in treatment of calcinosis universalis","volume":"84","author":"Lassoued","year":"1988","journal-title":"Am J Med"},{"key":"10.1111\/j.1529-8019.2012.01491.x-BIB1491-bib-0268|dth1491-cit-0268","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1002\/art.22158","article-title":"Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation","volume":"54","author":"Pachman","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2012.01491.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2012.01491.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T10:42:06Z","timestamp":1687516926000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2012.01491.x"}},"subtitle":["Management of cutaneous dermatomyositis"],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":268,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01491.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}